Pulse Biosciences
PLSE
11 hedge funds and large institutions have $1.37M invested in Pulse Biosciences in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.21% less ownership
Funds ownership: 1.82% → 1.6% (-0.21%)
15% less funds holding
Funds holding: 13 → 11 (-2)
40% less capital inflows, than outflows
Capital inflows: $288K | Capital outflows: $479K
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$233K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$26.7K |
| 3 |
BlackRock Fund Advisors
San Francisco,
California
|
+$22K |
| 4 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
+$5.92K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
-$212K |
| 2 |
Millennium Management
New York
|
-$193K |
| 3 |
Goldman Sachs
New York
|
-$54.4K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$14.8K |
| 5 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$3K |
PLSE Hedge Fund Activity: Q4 2016 in Review
11 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q4 2016, worth a combined $1.37M — down 9.8% from $1.52M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PLSE and 2 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Vanguard Group, opening a new position worth an estimated $233K. The largest seller was Spark Investment Management, exiting entirely with an estimated $212K sold.
- 11 institutional investors held Pulse Biosciences (PLSE) as of Q4 2016, down from 13 in Q3 2016.
- Funds reported $1.37M of Pulse Biosciences stock for Q4 2016, down 9.8% quarter-over-quarter.
- 2 funds opened new Pulse Biosciences positions in Q4 2016 and 4 closed out, a net change of -2 holders.
- The largest Pulse Biosciences buyer in Q4 2016 was Vanguard Group, an estimated $233K added.
- The largest Pulse Biosciences seller in Q4 2016 was Spark Investment Management, an estimated $212K sold.
Based on aggregated 13F filings for Q4 2016.